HUT64843A - Method for producing substituted cyclohexane derivatives - Google Patents
Method for producing substituted cyclohexane derivatives Download PDFInfo
- Publication number
- HUT64843A HUT64843A HU9302527A HU9302527A HUT64843A HU T64843 A HUT64843 A HU T64843A HU 9302527 A HU9302527 A HU 9302527A HU 9302527 A HU9302527 A HU 9302527A HU T64843 A HUT64843 A HU T64843A
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- compound
- hydroxy
- group
- hydrogen
- Prior art date
Links
- 0 O[C@](C[C@](C[C@]1OC(c2ccc(*Cc3ccccc3)cc2)=O)(C(O)=O)O)[C@]1O Chemical compound O[C@](C[C@](C[C@]1OC(c2ccc(*Cc3ccccc3)cc2)=O)(C(O)=O)O)[C@]1O 0.000 description 2
- HMFCRSKLXUFEPP-UHFFFAOYSA-N C=[O]C1C(C[O]#C)CCCC1 Chemical compound C=[O]C1C(C[O]#C)CCCC1 HMFCRSKLXUFEPP-UHFFFAOYSA-N 0.000 description 1
- QFJBZZPMSSVQFI-RMKNXTFCSA-N CC(C(CC(C1=C)OC(/C=C/c(cc2)ccc2O)=O)C(O)=O)C1=C Chemical compound CC(C(CC(C1=C)OC(/C=C/c(cc2)ccc2O)=O)C(O)=O)C1=C QFJBZZPMSSVQFI-RMKNXTFCSA-N 0.000 description 1
- OETSFOXBSYSUAB-UHFFFAOYSA-N CC1C=C(C)C=CC1O Chemical compound CC1C=C(C)C=CC1O OETSFOXBSYSUAB-UHFFFAOYSA-N 0.000 description 1
- LGAQBYWKWZHOKB-BIAAXOCRSA-N O[C@H](C[C@](C[C@H]1OC(c(cc2)ccc2O)=O)(C(O)=O)O)[C@H]1O Chemical compound O[C@H](C[C@](C[C@H]1OC(c(cc2)ccc2O)=O)(C(O)=O)O)[C@H]1O LGAQBYWKWZHOKB-BIAAXOCRSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/013—Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/383—Cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Transceivers (AREA)
- Mobile Radio Communication Systems (AREA)
- Pyridine Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4230156 | 1992-09-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9302527D0 HU9302527D0 (en) | 1993-11-29 |
| HUT64843A true HUT64843A (en) | 1994-03-28 |
Family
ID=6467599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9302527A HUT64843A (en) | 1992-09-09 | 1993-09-07 | Method for producing substituted cyclohexane derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5451573A (show.php) |
| EP (1) | EP0587087B1 (show.php) |
| JP (1) | JPH06211737A (show.php) |
| KR (1) | KR100299205B1 (show.php) |
| CN (1) | CN1042329C (show.php) |
| AT (1) | ATE181237T1 (show.php) |
| AU (1) | AU662836B2 (show.php) |
| CA (1) | CA2105707A1 (show.php) |
| CZ (1) | CZ284995B6 (show.php) |
| DE (1) | DE59309649D1 (show.php) |
| DK (1) | DK0587087T3 (show.php) |
| ES (1) | ES2135429T3 (show.php) |
| FI (1) | FI933902L (show.php) |
| GR (1) | GR3030953T3 (show.php) |
| HU (1) | HUT64843A (show.php) |
| IL (1) | IL106935A (show.php) |
| NO (1) | NO179671C (show.php) |
| PH (1) | PH30278A (show.php) |
| PL (1) | PL300328A1 (show.php) |
| RU (1) | RU2131248C1 (show.php) |
| TW (1) | TW255880B (show.php) |
| ZA (1) | ZA936610B (show.php) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4404848A1 (de) * | 1994-02-16 | 1995-08-17 | Hoechst Ag | Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate |
| DE4408082A1 (de) * | 1994-03-10 | 1995-09-14 | Hoechst Ag | Substituierte Propan-Derivate, Verfahren zu ihrer Herstellung und die Anwendung der Verbindungen zur Behandlung von Krankheiten |
| DE4416433A1 (de) * | 1994-05-10 | 1995-11-16 | Hoechst Ag | Cyclohexan-Derivate, Verfahren zu ihrer Herstellung und die Verwendung der Verbindungen zur Behandlung von Krankheiten |
| AR012449A1 (es) * | 1997-04-18 | 2000-10-18 | Hoechst Marion Roussell Deutschland Gmbh | Kodaistatinas a, b, c y d, proceso para su produccion, y su uso. |
| JP4810558B2 (ja) * | 1997-08-08 | 2011-11-09 | 江崎グリコ株式会社 | リン酸化糖およびその製造方法 |
| DE19740080A1 (de) * | 1997-09-12 | 1999-03-18 | Hoechst Marion Roussel De Gmbh | Neue Phthalaldehyd-Derivate, Verfahren zu deren Herstellung und deren Verwendung |
| ATE328103T1 (de) * | 1998-06-24 | 2006-06-15 | Sanofi Aventis Deutschland | Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel |
| PL205217B1 (pl) * | 1999-10-25 | 2010-03-31 | Sanofi Aventis Deutschland | Aromatyczne pochodne diketonowe i kompozycja farmaceutyczna zawierająca aromatyczne pochodne diketonowe |
| PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| EP2949652B1 (en) | 2004-06-03 | 2019-08-07 | Eisai R&D Management Co., Ltd. | Intermediates for the preparation of halichondrin B |
| ZA200700755B (en) * | 2004-07-26 | 2009-05-27 | Chugai Pharmaceutical Co Ltd | Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| CN104311571B (zh) | 2007-10-03 | 2019-07-02 | 卫材R&D管理有限公司 | 用于合成软海绵素b类似物的中间体和方法 |
| EP2274309B1 (en) | 2008-04-04 | 2015-07-29 | Eisai R&D Management Co., Ltd. | Halichondrin b analogs |
| US20100112098A1 (en) * | 2008-10-31 | 2010-05-06 | Naturex, S.A. | Effects of a decaffeinated green coffee extract on body weight control by regulation of glucose metabolism |
| CA2787919C (en) | 2010-01-26 | 2018-07-31 | Eisai R&D Management Co., Ltd. | Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs |
| HUE049387T2 (hu) | 2013-11-04 | 2020-09-28 | Eisai R&D Man Co Ltd | A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek |
| CN105916861B (zh) | 2013-12-06 | 2018-12-14 | 卫材R&D管理有限公司 | 可用于合成软海绵素b类似物的方法 |
| RU2739034C2 (ru) | 2015-05-07 | 2020-12-21 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Реакции макроциклизации и промежуточное соединение и другие фрагменты, полезные в синтезе макролидов галихондринов |
| RU2732575C2 (ru) | 2016-02-12 | 2020-09-21 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Промежуточные продукты в синтезе эрибулина и соответствующие способы синтеза |
| CN109641917B (zh) | 2016-06-30 | 2022-06-14 | 卫材R&D管理有限公司 | 可用于合成软海绵素大环内酯类及其类似物的普林斯反应和中间体 |
| IL275729B2 (en) | 2018-01-03 | 2023-09-01 | Eisai R&D Man Co Ltd | Prins reaction and compounds useful in the synthesis of helicondrin macrolides and their analogs |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60192555A (ja) * | 1984-03-13 | 1985-10-01 | Osaka Chem Lab | 抗アレルギ−食品 |
| JPS60243016A (ja) * | 1984-05-17 | 1985-12-03 | Tsumura Juntendo Inc | 抗インフルエンザウイルス剤 |
| EP0464859A1 (en) * | 1984-05-23 | 1992-01-08 | Green Cross Corporation | A lipoxygenase inhibitor |
| DE3603576A1 (de) * | 1986-02-06 | 1987-08-13 | Code Kaffee Handel | Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz |
-
1993
- 1993-09-03 TW TW082107191A patent/TW255880B/zh active
- 1993-09-06 DK DK93114260T patent/DK0587087T3/da active
- 1993-09-06 ES ES93114260T patent/ES2135429T3/es not_active Expired - Lifetime
- 1993-09-06 EP EP93114260A patent/EP0587087B1/de not_active Expired - Lifetime
- 1993-09-06 DE DE59309649T patent/DE59309649D1/de not_active Expired - Fee Related
- 1993-09-06 AT AT93114260T patent/ATE181237T1/de not_active IP Right Cessation
- 1993-09-07 PH PH46828A patent/PH30278A/en unknown
- 1993-09-07 US US08/116,564 patent/US5451573A/en not_active Expired - Fee Related
- 1993-09-07 HU HU9302527A patent/HUT64843A/hu unknown
- 1993-09-07 FI FI933902A patent/FI933902L/fi unknown
- 1993-09-07 IL IL10693593A patent/IL106935A/xx not_active IP Right Cessation
- 1993-09-08 CZ CZ931867A patent/CZ284995B6/cs not_active IP Right Cessation
- 1993-09-08 NO NO933201A patent/NO179671C/no not_active IP Right Cessation
- 1993-09-08 RU RU93045145A patent/RU2131248C1/ru active
- 1993-09-08 ZA ZA936610A patent/ZA936610B/xx unknown
- 1993-09-08 JP JP5223056A patent/JPH06211737A/ja not_active Abandoned
- 1993-09-08 AU AU46170/93A patent/AU662836B2/en not_active Ceased
- 1993-09-08 PL PL93300328A patent/PL300328A1/xx unknown
- 1993-09-08 CN CN93116663A patent/CN1042329C/zh not_active Expired - Fee Related
- 1993-09-08 CA CA002105707A patent/CA2105707A1/en not_active Abandoned
- 1993-09-09 KR KR1019930018066A patent/KR100299205B1/ko not_active Expired - Fee Related
-
1999
- 1999-08-11 GR GR990402034T patent/GR3030953T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO179671B (no) | 1996-08-19 |
| GR3030953T3 (en) | 1999-11-30 |
| ATE181237T1 (de) | 1999-07-15 |
| CZ186793A3 (en) | 1994-03-16 |
| CA2105707A1 (en) | 1994-03-10 |
| DE59309649D1 (de) | 1999-07-22 |
| TW255880B (show.php) | 1995-09-01 |
| NO933201L (no) | 1994-03-10 |
| NO179671C (no) | 1996-11-27 |
| KR940006580A (ko) | 1994-04-25 |
| IL106935A (en) | 1997-07-13 |
| EP0587087A1 (de) | 1994-03-16 |
| NO933201D0 (no) | 1993-09-08 |
| CN1086806A (zh) | 1994-05-18 |
| RU2131248C1 (ru) | 1999-06-10 |
| AU662836B2 (en) | 1995-09-14 |
| EP0587087B1 (de) | 1999-06-16 |
| KR100299205B1 (ko) | 2001-11-22 |
| FI933902A7 (fi) | 1994-03-10 |
| FI933902L (fi) | 1994-03-10 |
| IL106935A0 (en) | 1993-12-28 |
| AU4617093A (en) | 1994-03-17 |
| PH30278A (en) | 1997-02-20 |
| HK1011934A1 (en) | 1999-07-23 |
| HU9302527D0 (en) | 1993-11-29 |
| PL300328A1 (en) | 1994-03-21 |
| US5451573A (en) | 1995-09-19 |
| JPH06211737A (ja) | 1994-08-02 |
| CN1042329C (zh) | 1999-03-03 |
| FI933902A0 (fi) | 1993-09-07 |
| ES2135429T3 (es) | 1999-11-01 |
| ZA936610B (en) | 1994-03-28 |
| CZ284995B6 (cs) | 1999-04-14 |
| DK0587087T3 (da) | 1999-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT64843A (en) | Method for producing substituted cyclohexane derivatives | |
| RU2126378C1 (ru) | Замещенные производные циклогексана | |
| EP0061386B1 (fr) | Acides ((2-oxo-3-tétrahydrothiénylcarbamoyl)-alkylthio) acétiques, leurs sels et leurs esters, leur procédé de préparation et les compositions pharmaceutiques en contenant | |
| SE447116B (sv) | Nya spiro-oxazolidindioner och farmaceutiska beredningar innehallande desamma | |
| EP0011928A1 (en) | 3,5-Dihydroxypentanoic ester derivatives having antihyperlipaemic activity, their manufacture and pharmaceutical compositions containing them | |
| CA1334535C (en) | 6-substituted acyclopyrimidine nucleoside derivative and antiviral agent containing the same as active ingredient thereof | |
| EP1355887A1 (fr) | Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation | |
| EP0033617A2 (en) | Thiazolidine derivatives and their production and medicinal compositions containing them | |
| CA1100493A (fr) | Procede de preparation de nouveaux derives de la 11- desoxy prostaglandine f.sub.2 | |
| EP0180190B1 (en) | 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same | |
| US4220648A (en) | Antidiabetic 1,2-dihydro-2-oxo-6-neopentyl-nicotinic acids | |
| EP0591046A1 (fr) | Dérivés chromeniques à chaîne triénique, utilisables dans le traitement de l'ostéoporose et des affections inflammatoires | |
| US4219483A (en) | 4-Pyrone prostaglandin antagonists | |
| US4745185A (en) | D-arabinose-1,5-diphosphate salts and methods for the treatment of diabetes | |
| US5698585A (en) | Pharmaceutical preparation for prevention and/or treatment for cataract | |
| US4843093A (en) | Butyrolactone derivatives, process for production thereof and use therefor | |
| US4275069A (en) | Anti-diabetic 1,2-dihydro-2-oxo-6-alkyl-nicotinic acids | |
| CA1271191A (en) | Alpha-tocopherol (halo)uridine phosphoric acid diester, salts thereof, and methods for producing the same | |
| KR960011377B1 (ko) | 이미다졸유도체,그의제조방법및그를함유하는항궤양제 | |
| US5466830A (en) | Inhibition of bone loss by 4-aryloxy-5-hydroxy-2(5H)-furanones | |
| US4510323A (en) | Cis-bicyclo[3.3.0]octane derivatives, medicaments containing them and processes for their preparation and use | |
| CZ290065B6 (cs) | Substituované estery cyklohexanolu, jejich použití k léčení chorob a léčiva, která je obsahují | |
| IL93856A (en) | Substituted dibenzofurans and pharmaceutical compositions containing them | |
| US4378369A (en) | Esters of 2,5-anhydro-D-mannitol | |
| US4766127A (en) | 2-(3-pyridylmethyl)naphthalene-6-carboxylic acid as a thromboxane synthetase inhibitor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFA9 | Temporary protection cancelled due to abandonment |